443 related articles for article (PubMed ID: 23769805)
1. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
2. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
Cerasa A; Messina D; Pugliese P; Morelli M; Lanza P; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2011 Apr; 26(5):807-12. PubMed ID: 21384430
[TBL] [Abstract][Full Text] [Related]
3. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
[TBL] [Abstract][Full Text] [Related]
4. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement.
Cerasa A; Morelli M; Augimeri A; Salsone M; Novellino F; Gioia MC; Arabia G; Quattrone A
Parkinsonism Relat Disord; 2013 Jan; 19(1):123-5. PubMed ID: 22742954
[TBL] [Abstract][Full Text] [Related]
6. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
[TBL] [Abstract][Full Text] [Related]
7. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
[TBL] [Abstract][Full Text] [Related]
8. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.
Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A
Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050
[TBL] [Abstract][Full Text] [Related]
9. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
11. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
[TBL] [Abstract][Full Text] [Related]
12. Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
Mann RK; Edwards R; Zhou J; Jog M; Duval C
Clin Neurol Neurosurg; 2010 Jun; 112(5):392-9. PubMed ID: 20206438
[TBL] [Abstract][Full Text] [Related]
13. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets.
Koch G
Restor Neurol Neurosci; 2010; 28(4):561-8. PubMed ID: 20714078
[TBL] [Abstract][Full Text] [Related]
14. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Piccini P; Weeks RA; Brooks DJ
Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
16. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease.
Fabbrini G; Defazio G; Colosimo C; Suppa A; Bloise M; Berardelli A
Mov Disord; 2009 Oct; 24(14):2091-6. PubMed ID: 19691126
[TBL] [Abstract][Full Text] [Related]
17. Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.
Chelaru MI; Duval C; Jog M
J Neurosci Methods; 2010 Jan; 186(1):81-9. PubMed ID: 19878692
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
Kishore A; Popa T; Balachandran A; Chandran S; Pradeep S; Backer F; Krishnan S; Meunier S
Cereb Cortex; 2014 Aug; 24(8):2055-67. PubMed ID: 23535177
[TBL] [Abstract][Full Text] [Related]
19. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.
Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K
Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.
Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF
Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
